Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase II study of epacadostat with pembrolizumab in metastatic or unresectable gastroesophageal junction and gastric adenocarcinoma requiring paired biopsies. Kardosh, A., Tseng, D., Sahaf, B., Zomet, A., Krupa, J., Fisher, G. A., Wang, D. S., Mackall, C., Kunz, P. L. AMER SOC CLINICAL ONCOLOGY. 2018
View details for DOI 10.1200/JCO.2018.36.4_suppl.TPS191
View details for Web of Science ID 000436174100183